3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Colorectal Neoplasms
57
Carcinoma, Non-Small-Cell Lung
29
Breast Neoplasms
18
Rectal Neoplasms
14
Ovarian Neoplasms
14
Carcinoma, Hepatocellular
10
Neoplasm Metastasis
9
Glioblastoma
9
Colonic Neoplasms
9
Carcinoma, Renal Cell
8
Uterine Cervical Neoplasms
7
Fallopian Tube Neoplasms
7
Brain Neoplasms
6
Neoplasms
5
Nasopharyngeal Carcinoma
5
Lung Neoplasms
5
Triple Negative Breast Neoplasms
4
Recurrence
4
Liver Neoplasms
4
Inflammatory Breast Neoplasms
4
Colorectal Cancer Metastatic
4
Carcinoma, Ovarian Epithelial
4
Stomach Neoplasms
3
Pleural Effusion, Malignant
3
Meningeal Carcinomatosis
3
Melanoma
3
Kidney Neoplasms
3
Glioma
3
Non-squamous Non-small Cell Lung Cancer
2
Liver Metastasis Colon Cancer
2
Interventions
Amplified Fragment Length Polymorphism Analysis
2
entrectinib
1
Vinorelbine
1
Trastuzumab
1
Radiomics
1
Pharmacogenomic Testing
1
Neoadjuvant Therapy
1
Molecular Diagnostic Techniques
1
Letrozole
1
Goserelin
1
Gene Expression Profiling
1
Epirubicin
1
Docetaxel
1
Cyclophosphamide
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Lobular
×
Bevacizumab
×
Clear all
NCT01641406
2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2
Unknown
60 enrolled